Correlation Between CTS and TNF Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both CTS and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTS and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTS Corporation and TNF Pharmaceuticals,, you can compare the effects of market volatilities on CTS and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTS with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTS and TNF Pharmaceuticals,.

Diversification Opportunities for CTS and TNF Pharmaceuticals,

-0.72

Correlation Coefficient

CTS  TNF Pharmaceuticals,

Pay attention - limited upside

The 3 months correlation between CTS and TNF is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding CTS Corp. and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and CTS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTS Corporation are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of CTS i.e., CTS and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between CTS and TNF Pharmaceuticals,

Considering the 90-day investment horizon CTS Corporation is expected to generate 0.35 times more return on investment than TNF Pharmaceuticals,. However, CTS Corporation is 2.89 times less risky than TNF Pharmaceuticals,. It trades about 0.1 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about -0.07 per unit of risk. If you would invest  4,854  in CTS Corporation on September 26, 2024 and sell it today you would earn a total of  488.00  from holding CTS Corporation or generate 10.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CTS Corp.  vs.  TNF Pharmaceuticals,

CTS Corporation

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CTS Corporation are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CTS may actually be approaching a critical reversion point that can send shares even higher in January 2025.

TNF Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with CTS and TNF Pharmaceuticals,

The main advantage of trading using opposite CTS and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTS position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.

The idea behind CTS Corporation and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.